Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TODOS has released a string of News yet the shareprice is down to 1 cent above our 52 week Low.
Just the announced intent/threat of a Reverse Split has done this.
It is likely cheaper to produce their own Gromwell Root (aka Lithospermum Erythrorhizon) and it is also important for quality control.
Some root products contain other things picked up in the soil so it is important that the company tests for the possible presence of things like pyrrolizidine alkaloids which are sometimes found in the root depending on where it is harvested?
This would be important if someone was to use their product for an extended period.
I contacted Todos with that question and received a reply that they do test for that and based on their safety report, do not have any concerns regarding extended use of Tollovid.
Interesting , thanks for posting
Thanks rokky, I expect i will have no choice now
I H Admin has suggested that if anyone here has had posts removed from this thread for little cause to contact them ASAP.
It's been fun Good Luck All
There is a reverse split coming and we appear to be creating a Newco to handle Tollovid and Tollovir and this private Newco....3CL Whatever (not sure the name) is going to raise million$ in a crowd funding deal then spin off from Todos and NCL (private) as a Public traded company, and all over a product that is based on a Root extract that is availble over the counter.
What's not to love?
Would Todos be doing the reverse split before or after 3CL split off and go Public as it's own identity one day in the future as the CEO said it could?
Thank you Sloan. That is an amazing account and nobody knows ourselves better than we do, So I really appreciate the detail and comparisons in your story. Stating those statistics (heart rate) and the fact that you were more than exposed had mild symptoms and bounced back so strongly with no lasting effect is awesome.
Thanks for sharing.
The way I see it is TOMDF team up with a private company (NCL ) to share their IP. Todos and NCL Pharma start a 3rd (private) company that will take most of the workload for product development and 3CL Pharma, the newco will go ahead with a crowd funding program to raise capital to develop and produce and that Todos will own 52 % of 3CL which may split off and go Public as it's own identity one day in the future.
When the crowdfunding is announced we will find out what investors get for their investment and if it could mean more dilution?
Phase 2 for Tollovir is being extended with hopes of EUA as a possible result
Hope I have this right
Yes I see what you mean, volume is quite lower than usual and in this case that is a good thing.
Lotsa news today and the market wants more LOL
wow that's amazing, thanks Griff
I feel really strong against the reverse split. I'm a long term holder but that announcement on the Proxy just threw me and now I'm struggling with my gamble on this company.
If it wasn't for the potential split I would be fine and likely buying more on this dip. I hold other Penny stocks as well
What exactly will TOMDF do to make sure that the split will succeed when most others fail?
I'd be curious also what Gerald and the BOD are going to do to ensure that the R/S succeeds after the split and doesn't revert back to 2 cents.
Perhaps a string of good news , I wonder
Tollovid : I asked earlier today if any here use or have used Tollovid and was surprised that some answered.
Is yes, have you had any good health improvement or changes or testimonials that you would care to share.
I'm a firm believer of benefits of TCM and there is so much data out there on it, quite surprising.
Slightly off topic: "Interestingly, of the new anticancer drugs developed between 1940 and 2002, approximately 54% were derived from natural products .
Another study has determined that of all current pharmaceutical products, about 73%, include ingredients derived from natural products . "
That's pretty cool, eh?
(2 posts left for today)
Post 12,000 So what was it that caused this stock to fall from .644 earlier in the year?
What drove that?
Possible answer:
History shows .644 on January 13 so it's likely a glitch of some sort. maybe someone accidentally bot shares at the wrong price .....otherwise the true 52 week high would have been .1047 on Nov29, 2021. Wouldn't that be a nice pop?
I know what you're thinking "will you shut up man?"....who said that?
But the fact is promises don't move this stock anymore....I'm down 28% since last month and there are only 5 people posting here....doesn't anyone lurking have an opinion or have you given up posting. "You know who" need not reply
Crowdfunding, good question but don't expect answers here apparently we are supposed to keep silent and go away ....but Todos align with a company to get better handle on Tollovid and the two companies , one private and one public join together and create a new private company and the first thing they do is start a crowdfunding scheme to raise money for Tollovir promotion /production and because Tollovid is already tested on people then FDA should grant EUA from results of Phase 2. Is crowdfunding even legal for a Public traded company or does arms lengthening it make it okay? Right so far on my DD?
Looks like things are moving
News Out
Todos Medical Partner NLC Pharma Assigns IP for Tollovirâ„¢, Tollovidâ„¢, and TolloTestâ„¢ into JV 3CL Pharma
September 12, 2022 09:15 ET | Source: Todos Medical Ltd.
How is Tollovir different from Tollovid. Are there different ingredients, is it a stronger version?
Yes pretty fine, i must say
Nice to see Tollovid in use by members here. I haven't tried it yet. Do you see/feel any health benefits from it aside from the obvious preventative use ?
I was just looking at Tollovid $150 plus shipping, not bad if you need it
Anyone here tried Tollovid?
Any here that would prefer no split....another company I know had a charter in their rulebook that promised to never do a rev/split
I'd be curious to know if there are others here that would prefer no split....another company I know had a charter in their rulebook that promised to never do a rev/split
I never knew that, it sure sounds unfair,,,,sorta like some TV shows where you can vote multiple times
Why do they want to raise the number of authorized shares from 5 billion to 10 billion when they plan on doing a split, seems counter productive
Question: Can an individual vote multiple times on one item at an AGM, or is it 1 vote per item per individual
You should re read the Proxy.....you have it mixed up....and BTW Rev splits on penny stocks don't work, after the r/s it has further to fall and plays into the hands of shorts and hedges.....often the company that loans the money post split will hedge their loan. Once the stock fall post split then milestone agreements fail to be met and the loans from those lenders are cancelled , the stock falls and hedgers and shorts win
redspeed :
"Re: red-one post# 11856
Friday, September 09, 2022 10:14:
I already voted yes 5 times."
How did you do that?
Just the announcement of intentions to split will cause the present shareprice to fall further , then once the split happens the shareprice has even further to fall...not rocket science
OMG posting a link from the NasDaq promoting rev splits, how silly is that, c'mon man just let others decide for themselves.
BTW: 1. Don't fall in love with any stock ...
2. Don't risk too much on one event or company... this is usually the result of investors not paying attention to Rule #1
Being Long in a penny stock is not an investment it is , at best an educated bet.
Once you realize this, it could help you to avoid losing
GPR only announced a R/S shareprice went from .16 to .125,
Dec only announced a R/S shareprice went from .125 to .105,
Vaxil only announced a R/S shareprice went from .05 to .03,
Clas-v did a split last year the pre split price was .025 and a 20 to 1 R/S went ahead......1 year later the shareprice is back down to .025 again since the split and the company is now under a CTO because they have no money, it's done, finished
...and then they fail. If you feel that buying a 2 cent stock is an "Investment" I have some prime real estate for you in central Florida.....don't fall in love with a stock
The latest request to vote asks for shareholders to vote to allow BOD to authorize a rev/split.....vote no this time regardless what other Longs have to say....rev splits in penny pharma stocks don't work
If they don't need retail then email them with your concerns
Don't assume that someone who doesn't the r/s is new to the stock and hasn't done his/her DD , that's nonsense
" If a new shareholder is so overly concerned about the possibility of a RS at this price, they shouldn't be invested here." KMA
Longs shouldn't use their position to force others to vote poorly
I am certainly re-evaluating a desire to be invested here or buy more shares and judging by the increased sell off since the Proxy , I think others are as well.
Just the announcement of an intent to R/S is a stock killer
Not a concern for you , well it sure as heck should be
Never fall in love with a stock, you lose perspective among other things
Too bad for Todos , I had great hopes for this company until now
Longs, give you heads a shake
The trap here is that the BOD likely are encouraging G to do something now to attract Institutional Investors. The reverse split and these splits do not work with Penny pharma stocks
Did you and your family use Tollovid?
Just by announcing intention to split (on the Proxy vote paper) they have driven this stock down..... folks who know are better bailing out. We all need to start emailing Todos demanding they don't split
I think once school has been back for a few weeks and the media start reporting real Covid numbers again there will be an upsurge of attention and maybe companies like Todos will get an opportunity to compete (EUA) with Big Pharma who appear to have dropped the ball again. The consensus on Covid is that it is 4 x worse now than it was last year